CD4(+) T cell activation and inflammation in NASH-related fibrosis.
CD4(+) T cell activation and inflammation in NASH-related fibrosis.
复制标题
DOI:
10.3389/fimmu.2022.967410
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
Zheng, Feng
中科院分区:
文献类型:
--
作者:
Zhou, Yunfeng;Zhang, Haibo;Yao, Yao;Zhang, Xiaoyan;Guan, Youfei;Zheng, Feng
Liver fibrosis is a common pathological feature of end stage liver failure, a severe life-threatening disease worldwide. Nonalcoholic fatty liver disease (NAFLD), especially its more severe form with steatohepatitis (NASH), results from obesity, type 2 diabetes and metabolic syndrome and becomes a leading cause of liver fibrosis. Genetic factor, lipid overload/toxicity, oxidative stress and inflammation have all been implicated in the development and progression of NASH. Both innate immune response and adaptive immunity contribute to NASH-associated inflammation. Innate immunity may cause inflammation and subsequently fibrosis via danger-associated molecular patterns. Increasing evidence indicates that T cell-mediated adaptive immunity also provokes inflammation and fibrosis in NASH via cytotoxicity, cytokines and other proinflammatory and profibrotic mediators. Recently, the single-cell transcriptome profiling has revealed that the populations of CD4+ T cells, CD8+ T cells, γδ T cells, and TEMs are expanded in the liver with NASH. The activation of T cells requires antigen presentation from professional antigen-presenting cells (APCs), including macrophages, dendritic cells, and B-cells. However, since hepatocytes express MHCII molecules and costimulators, they may also act as an atypical APC to promote T cell activation. Additionally, the phenotypic switch of hepatocytes to proinflammatory cells in NASH contributes to the development of inflammation. In this review, we focus on T cells and in particular CD4+ T cells and discuss the role of different subsets of CD4+ T cells including Th1, Th2, Th17, Th22, and Treg in NASH-related liver inflammation and fibrosis.
登录
查看更多内容
DOI:
10.1111/dom.14322
发表时间:
2021-05
期刊:
Diabetes, obesity & metabolism
影响因子:
--
作者:
Cariou B;Byrne CD;Loomba R;Sanyal AJ
通讯作者:
Sanyal AJ
DOI:
10.1038/nri3405
发表时间:
2013-04
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
影响因子:
25.7
作者:
Gaul S;Leszczynska A;Alegre F;Kaufmann B;Johnson CD;Adams LA;Wree A;Damm G;Seehofer D;Calvente CJ;Povero D;Kisseleva T;Eguchi A;McGeough MD;Hoffman HM;Pelegrin P;Laufs U;Feldstein AE
通讯作者:
Feldstein AE
影响因子:
5.8
作者:
Dixon LJ;Barnes M;Tang H;Pritchard MT;Nagy LE
通讯作者:
Nagy LE
影响因子:
8
作者:
Bieghs, Veerle;Trautwein, Christian
通讯作者:
Trautwein, Christian